Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.2K Buy
6,634
+6,632
+331,600% +$8.19K ﹤0.01% 8967
2025
Q4
$3 Sell
2
-344
-99% -$710 ﹤0.01% 10418
2025
Q3
$844 Buy
346
+344
+17,200% +$846 ﹤0.01% 9525
2025
Q2
$5 Buy
+2
New +$5 ﹤0.01% 10176
2024
Q4
Sell
-2,744
Closed -$7.08K 10256
2024
Q3
$7.08K Buy
+2,744
New +$7.15K ﹤0.01% 7939
2024
Q2
Sell
-109
Closed -$298 9927
2024
Q1
$298 Sell
109
-46
-30% -$112 ﹤0.01% 8643
2023
Q4
$330 Buy
+155
New +$299 ﹤0.01% 8723
2023
Q3
Sell
-5,607
Closed -$14K 9820
2023
Q2
$14K Buy
5,607
+4,928
+726% +$9.64K ﹤0.01% 7025
2023
Q1
$869 Sell
679
-4,438
-87% -$6.44K ﹤0.01% 8882
2022
Q4
$6.4K Sell
5,117
-4,913
-49% -$6.73K ﹤0.01% 9037
2022
Q3
$15K Buy
10,030
+7,692
+329% +$13.6K ﹤0.01% 7816
2022
Q2
$4K Sell
2,338
-1,155
-33% -$1.88K ﹤0.01% 9093
2022
Q1
$7K Sell
3,493
-1,541
-31% -$3.46K ﹤0.01% 8833
2021
Q4
$13K Buy
+5,034
New +$14.8K ﹤0.01% 8462

Other funds holding NXGL

UBS Group's NXGL Position: Q1 2026 in Review

UBS Group increased its NexGel (NXGL) stake by 331,600% in Q1 2026, buying an estimated $8.19K and bringing the position to 6,634 shares worth $4.2K. The position accounts for ﹤0.01% of the portfolio, ranked #8967.

UBS Group first reported a position in NXGL in Q4 2021 and has held it in 14 quarters since. The position peaked at $15K in Q3 2022. 18 funds tracked by Wall St. Rank hold NXGL as of Q1 2026.

  • UBS Group held 6,634 shares of NexGel worth $4.2K as of Q1 2026.
  • UBS Group bought 6,632 NexGel shares in Q1 2026, an estimated $8.19K.
  • NexGel made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #8967 holding.
  • UBS Group first reported a position in NexGel in Q4 2021 and has held it in 14 quarters since.
  • UBS Group's NexGel position peaked at $15K in Q3 2022.
  • 18 funds tracked by Wall St. Rank held NexGel as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.